CONSTITUENT REPORT
Neral
Neral is the Z isomer of citral, the lemon-scented monoterpene aldehyde pair better known together as citral. The current evidence base is strongest for identity, fragrance-allergy relevance, and preclinical antifungal work rather than for human wellness outcomes. Public studies support direct patch-test positivity in dermatitis patients and show that neral can participate in oxidation and skin-metabolism pathways tied to fragrance sensitization, while a full-text antifungal paper found it active against Trichophyton rubrum but less potent than geranial.
Chemical identity and composition
PubChem and NIST both identify neral as C10H16O with the Z geometry of 3,7-dimethylocta-2,6-dienal. In essential-oil chemistry it is the cis or Z citral isomer, paired with geranial as the combined citral fraction that gives a sharp lemon note to lemongrass, melissa, litsea cubeba, lemon verbena, and related oils.
Aroma and practical use
- Use the recorded lemony, fresh, citrusy, aldehydic, softer than geranial, citrus, soft lemon peel descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2020 dermatitis paper reported positive patch-test reactions to neral in 1.9% of 1476 patients and concluded that geranial and neral behave as separate haptens.
This is the clearest direct human safety signal for isolated neral in the reviewed literature.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A 2021 full-text paper found that neral inhibited Trichophyton rubrum and affected sterol patterns associated with ERG6 disruption, although geranial was more potent across several assays.
This supports keeping neral's bioactivity discussion narrow, preclinical, and clearly differentiated from the stronger geranial result in the same study.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2007 autoxidation study concluded that geraniol air exposure forms aldehydes including geranial and neral and that the oxidized samples showed moderate sensitizing capacity in LLNA testing.
For archive purposes, this matters less as a benefit study than as an explanation for why neral appears in fragrance-allergen discussions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2008 skin-like CYP study identified neral among geraniol metabolites and reported that geranial and neral were moderate sensitizers in LLNA testing.
This adds a metabolism-based mechanism to the simpler air-oxidation story and supports conservative safety framing for citral-linked fragrance systems.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedHuman patch-testing supports neral as a relevant fragrance allergen and shows that it should not be collapsed completely into geranial for sensitization interpretation.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
No direct public citation is attached to this entry.
Oxidation and skin-metabolism studies indicate that neral can arise from geraniol and participate in broader fragrance-allergen formation pathways.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
No standalone human efficacy trial for isolated neral was verified in this pass, so bioactivity language should remain explicitly preclinical and non-medical.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
geranialAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read geranial report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →citronellalAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citronellal report →CuminaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Cuminaldehyde report →(E)-cinnamaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read (E)-cinnamaldehyde report →gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
mechanistic · antioxidant
No source citation attached.
Read gamma-Terpinene report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · effect
No source citation attached.
Read Eugenol report →How the effects were investigated
ergosterol_biosynthesis_disruption_in_fungal_models
The 2021 T. rubrum paper indicates that neral alters sterol patterns consistent with ERG6-linked inhibition of ergosterol biosynthesis, supporting a membrane-focused antifungal mechanism.
This experimental finding does not establish benefit, dose or safety in people using this blend.
formation_via_geraniol_autoxidation_and_skin_metabolism
Autoxidation and skin-like CYP metabolism studies show that geraniol can generate neral, providing a mechanistic route by which fragrance mixtures gain additional sensitizing aldehydes over time or during cutaneous processing.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- The direct isolated-neral literature is much thinner than the broader citral literature, so many accessible claims still come from isomer-comparison or fragrance-allergy contexts.
- A directly verified public leave-on dermal concentration limit specific to isolated neral was not confirmed in this pass.
- No standalone human efficacy evidence for isolated neral was verified.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.